Table 5.
Univariate and multivariate relative risks for recurrence of cardiovascular disease and all-cause mortality in the good adherence subgroup
Univariate | Multivariate§ | |||
---|---|---|---|---|
Outcome predictor | RR | 95% CI | RR | 95% CI |
Cardiovascular recurrence | ||||
Within statin adherence≥80% subgroup | ||||
Adherence to aspirin (%) | ||||
<80 | 1.00 | 1.00 | ||
80–100 | 1.22 | 0.98, 1.52 | 1.03 | 0.76, 1.39† |
Within aspirin adherence≥80% subgroup | ||||
Adherence to statin (%) | ||||
<80 | 1.00 | 1.00 | ||
80–100 | 0.88 | 0.72, 1.08 | 0.76 | 0.62, 0.94* |
All-cause mortality | ||||
Within statin adherence≥80% subgroup | ||||
Adherence to aspirin (%) | ||||
<80 | 1.00 | 1.00 | ||
80–100 | 1.22 | 0.80, 1.84 | 0.73 | 0.44, 1.22† |
Within aspirin adherence≥80% subgroup | ||||
Adherence to statin (%) | ||||
<80 | 1.00 | 1.00 | ||
80–100 | 0.80 | 0.56, 1.15 | 0.72 | 0.50, 1.05 |
Adjusted for age, gender, social deprivation, calendar year, diabetes mellitus, cardiovascular drug use during follow-up and number of cardiovascular prescriptions.
Also adjusted for interaction between aspirin adherence and nonsteroidal anti-inflammatory drug use.
P < 0.05; ** P < 0.01.